Navigation Links
Tailoring Breast Cancer Treatment, from Harvard Women's Health Watch
Date:10/6/2009

Breast cancer, once thought to be a single disease, is turning out to be a collection of somewhat different disorders.

Boston, MA (Vocus) October 6, 2009 -- Breast cancer, once thought to be a single disease, is turning out to be a collection of somewhat different disorders. That knowledge is tempering the approach to treatment as experts begin using gene-based information to individualize therapies, reports the October 2009 issue of Harvard Women's Health Watch.

A key focus of breast cancer research today is identifying specific genes and protein receptors that can distinguish resistant forms of cancer from those that are easier to eradicate. In the process, it has become clear that breast cancer comes in different forms that respond to varying treatments.

The discovery of the BRCA genes in 1994 transformed approaches to prevention in women who are at high risk for breast cancer. Women carrying one of these harmful genes have options: screening via frequent mammograms and breast MRI scans, taking the drug tamoxifen to reduce the risk, or undergoing double mastectomy. Most breast cancer, though, isn't hereditary. Gene mutations are involved, but rather than being passed down from generation to generation, they crop up when errors occur in the DNA duplication process during cell division.

Advances in understanding the molecular basis of cancer have led to greater precision in identifying which tumors are more likely to recur and in targeting treatment. Harvard Women's Health Watch notes that cancer specialists are using gene-based diagnostic tests in various ways to plan more effective treatments: to determine which women are at high risk of recurrence and could benefit from chemotherapy in addition to tamoxifen; to identify women who might benefit from chemotherapy along with the drug Herceptin before surgery; and to identify women who carry certain forms of genes that help metabolize specific drugs.

Read the full-length article: "Molecular advances in early breast cancer"
Also in this issue:

 
  • Going vegetarian
  • New osteoporosis drug
  • Psychodynamic therapy for anxiety
  • Renessa for urinary incontinence
  • Knee replacement

Harvard Women's Health Watch is available from Harvard Health Publications (www.health.harvard.edu), the publishing division of Harvard Medical School, for $28 per year. Subscribe at www.health.harvard.edu/womens or by calling 877-649-9457 (toll-free).

Media: Contact Raquel Schott at Raquel_Schott@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.

Contact:
Raquel Schott
Harvard Health Publications
617-432-5781

# # #

Read the full story at http://www.prweb.com/releases/breast_cancer/treatment/prweb3002894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tailoring glioblastoma therapies: 1 size does not fit all
2. The Childrens Hospital of Philadelphia Receives Grant to Study Tailoring Pediatric Preventive Care to Individual Needs
3. An Aid to Tailoring Prostate Cancer Treatment
4. Japanese Fine Tailoring Revolutionizes Traditional Doctor Coats
5. Survival differences by race most apparent in advanced stages of breast cancer
6. MRI finds breast cancer before it becomes dangerous
7. Pathway links inflammation, angiogenesis and breast cancer
8. Drop in breast cancer incidence linked to hormone use, not mammograms
9. Breast cancer prevention practices vary across Canada
10. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
11. Acrylamide Wont Raise Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , ... May 05, 2016 , ... Einstein Medical ... Twitter feed to cover the latest news and commentary at the 2016 ASCRS/ASOA Symposium ... meeting of the American Society of Cataract and Refractive Surgery and the American Society ...
(Date:5/5/2016)... ... May 05, 2016 , ... TLC Laser Eye Centers ... California. The laser eye center will now be called “Gordon Schanzlin New Vision Institute, ... will remain at the full-service facility to ensure that patients continue to receive the ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... successful results with IVF and with egg freezing, today announced the grand opening ... and highest quality fertility care, Spring Fertility offers both fertility preservation (egg, sperm, ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Seminars for Business Journalists , led by the Wharton School’s most prominent ... issues.  This one-day program at the Wharton School’s San Francisco campus will ...
(Date:5/5/2016)... Indianapolis, IN (PRWEB) , ... May 05, 2016 ... ... employee benefits advisory organization, announces McLaughlin & Smoak Benefits as the latest addition ... & Smoak Benefits has a dedicated team of compliance, wellness, human resources, and ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016  While you may be familiar with watching a film or ... also known as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized ... innovative technology. Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... Inc. (NYSE: DPLO) announced today that it is celebrating Hepatitis Awareness Month with a campaign ... their personal story and encourage those at risk to get tested and begin the road ... ... ... Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... 3, 2016 According to market ... Development, Growth and Demand Forecast to 2022 - Industry ... (High Field, Very High Field, Low to Mid Field, ... Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, Cardiac, ... imaging (MRI) market was valued at $5,351.7 million in ...
Breaking Medicine Technology: